Fiche publication
Date publication
mars 2026
Journal
Cornea
Auteurs
Membres identifiés du Cancéropôle Est :
Dr GOETZ Christophe
Tous les auteurs :
Delean S, Goetz C, Zevering Y, Perone JM
Lien Pubmed
Résumé
Descemet membrane endothelial keratoplasty (DMEK) is the gold standard treatment for Fuchs endothelial corneal dystrophy (FECD). It is generally conducted mo/yr or immediately after lens phacoemulsification (pseudophakic-DMEK and triple-DMEK, respectively). A recent meta-analysis reported that mean central corneal thickness (CCT) 6 to 12 months after pseudophakic/triple-DMEK in Western European patients was 522 μm. However, mean CCT in healthy Western Europeans is 552 μm. This retrospective cohort study tested whether post-DMEK CCT in FECD eyes is thinner than normal by comparing consecutive pseudophakic/triple-DMEK eyes to consecutive cataract-surgery control eyes.
Mots clés
Descemet membrane endothelial keratoplasty, Fuchs endothelial corneal dystrophy, central corneal thickness, phacoemulsification, pseudophakic-DMEK, triple-DMEK
Référence
Cornea. 2026 03 11;: